Guidelines for a NIOSH policy on occupational carcinogenesis.

Details

• Personal Author:
  Fairchild EJ II
• Description:
  The development of NIOSH policy on carcinogenesis is discussed. Guidelines were formulated on the basis of consultation with experts in the scientific disciplines of carcinogenesis; by review of documents for the safety of drugs and food additives; from recent court rulings concerning ethyleneamine and 3,3-dichlorobenzidine (1331471); upon recent regulatory decision-making processes concerning aldrin (309002) and dieldrin (60571); and by congressional mandate of the 1970 Occupational Safety and Health Act. The intelligence system for recognition and priority setting of carcinogens will utilize all available input. NIOSH policy for carcinogenic substances in the future will be recommendation of the use-permit and registration system in addition to the no detectable exposure. [Description provided by NIOSH]
• Subjects:
  Carcinogens Neoplasms Occupational Health Safety
• Keywords:
  Cancer Carcinogenicity Legislation NIOSH-Author Regulations
• ISBN:
  9780890720509
• ISSN:
  0077-8923
• Document Type:
  Text
• Genre:
  Journal Article
• Place as Subject:
  Ohio ; OSHA Region 5
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  OD - Office of the Director
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  200-207
• Volume:
  271
• Issue:
  1
• NIOSHTIC Number:
  nn:00056695
• Citation:
  Ann NY Acad Sci 1976 May; 271(1):200-207
• Contact Point Address:
  Edward J. Fairchild, II, National Institute for Occupational Safety and Health, Cincinnati, Ohio 45202
• CAS Registry Number:
  Aldrin (CAS RN 309-00-2) ; Dichlorobenzidine (CAS RN 1331-47-1) ; Dieldrin (CAS RN 60-57-1)
• Federal Fiscal Year:
  1976
• Peer Reviewed:
  True
• Source Full Name:
  Annals of the New York Academy of Sciences
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:568127adb7a71cc464dacd7d4190c995fe1690f508f2ea45342804fd7fac2d55656ba35f1b028e91aa78008d692e6fc6c088e02f53b18e27ee80061e543130bb
• Download URL:
  https://stacks.cdc.gov/view/cdc/184103/cdc_184103_DS1.pdf
• File Type:
  [PDF - 488.33 KB ]